Aperam initiated with a Buy at Jefferies

Jefferies analyst Tommaso Castello initiated coverage of Aperam with a Buy rating and EUR 35 price target. With earnings close to trough and projected EBITDA improvements off the lows into 2025, investors “can benefit from a cheap valuation,” solid balance sheet and smart capital allocation, the analyst tells investors in a research note.